3-(4,5-Dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide (MTT) causes AKt phosphorylation and morphological changes in intracellular organellae in cultured rat astrocytes

Ichiro Isobe, Katsuhiko Yanagisawa, Makoto Michikawa

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

3-(4,5-Dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide (MTT) is widely used for cell viability and cytotoxicity assays, but cell biological effects of MTT itself have not been investigated. In this paper we show that MTT induces a morphological change in an intracellular membranous compartment labeled with anti-Rab5 antibody, dissociation of early endosomal auto-antigen (EEA1) from the membrane fraction, and phosphorylation of Akt probably through a phosphatidy-linositol-3-OH kinase [Pl(3)K] pathway in cultured rat astrocytes. These findings suggest that MTT affects cellular functions and conditions to some extent, and such effects of MTT may cause some discrepancies of measurement of cell viability using MTT assay and other assays. That is, the effects of MTT on cells could influence the results of cell viability assay. Moreover, MTT or other tetrazolium salts could be used as interesting activators of Akt to investigate the mechanism by which Akt or Pl(3)K is activated.

Original languageEnglish
Pages (from-to)274-280
Number of pages7
JournalJournal of neurochemistry
Volume77
Issue number1
DOIs
Publication statusPublished - 2001
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of '3-(4,5-Dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide (MTT) causes AKt phosphorylation and morphological changes in intracellular organellae in cultured rat astrocytes'. Together they form a unique fingerprint.

Cite this